Canadian Press file photo

By EverythingGP Staff

VITT

AstraZeneca linked death confirmed in Alberta

May 4, 2021 | 10:22 PM

Chief Medical Officer of Health Dr. Deena Hinshaw issued a statement late Tuesday night saying Alberta has confirmed the death of a woman in her 50’s from vaccine-induced immune thrombotic thrombocytopenia (VITT) after receiving the AstraZeneca COVID-19 vaccine.

The death is the first in Alberta caused by VITT and was just the second total case out of the 253,000 doses of AstraZeneca vaccine administered in the province.

“While any death is tragic, it is important to remember that the risks of dying or suffering other severe outcomes from COVID-19 remain far greater than the risk following AstraZeneca vaccine.”

Hinshaw adds the global frequency of VITT has been estimated at approximately one case in 100,000 to 250,000 doses of vaccine. That is in comparison to Albertans 50 to 59 who are diagnosed with COVID-19 being 350 times more likely to die from that infection than to experience VITT after an AstraZeneca vaccine.

“They are also at least 1,500 times more likely to be hospitalized from COVID-19 than experiencing VITT after getting AstraZeneca.”

Meaningful Mementos

Remembering Someone You've Lost at Christmas

Dec 03, 2024

Seasonal Sorrow

How Do You Get Through The Holidays When You're Grieving?

Nov 01, 2024

Upcoming Events at Oliver's

Grief & Loss and Estate Planning Seminars

Oct 02, 2024

Across Canada, there have been seven reported cases of VITT following 1.7 million doses of AstraZeneca vaccine being administered.